Introducing
Magnetic Resonance Histopathology
(MRH)
MRH is a novel MRI based software method that non-invasively measures tissue texture at the micro level (sub 1mm). MRH is a valuable tool to help Radiologist detect signs of early cancer or other diseases and potentially will lead to a safer, less invasive, more accurate, and less costly alternative to the routine practice of surgical biopsies. This advancement could possibly allow for earlier detection of many diseases and cancers and enable more accurate therapies sooner in the disease cycle to improve patient outcomes and lower medical costs.
Benefits of
Magnetic Resonance Histopathology (MRH)
Proprietary MRI Pulse Sequence
Our proprietary MRI Pulse sequence signal captures novel data about the tissue microarchitecture by targeting specific spatial wavelengths, providing unparalleled insight into tissue texture and structural differences for more accurate diagnosis.
Compatible with DICOM Protocols
MRH data is fully compatible with DICOM protocols, ensuring seamless integration with existing medical imaging workflows for efficient data transfer, storage, and analysis across any DICOM-compliant platforms and to the BioProtonics Cloud where AI Analytics is accessed.
Little Time Added to Your Existing MRI Scan
MRH protocol is designed to seamlessly integrate into a standard MRI exam with minimal impact on scan duration. The process adds as little as 90 seconds to the overall procedure, making it a highly efficient, without significantly extending the patient's time in the scanner.
Digital Biopsy with Advanced AI Analysis
Our advanced AI analysis compares MRH data like a Digital Biopsy comparing with ground truth biopsy results to enhance early diagnosis by identifying subtle differences in tissue structure. This comparison ensures highly accurate detection of abnormalities, helping clinicians diagnose diseases at an earlier stage for more effective intervention.
Advancing MRI Technology & Capability
90M
MRI Scans Worldwide per Year
45K
MRI Machines Worldwide
30M
MRI Scans in the USA per Year
1M
MRI Scans for Prostate Cancer Screening
40%
False Negative Results with Prostate Biopsys